Cardiff Oncology
CRDF
CRDF
26 hedge funds and large institutions have $16.2M invested in Cardiff Oncology in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Holders
26
Holding in Top 10
–
Calls
$76K
Puts
$7K
Top Buyers
| 1 | +$1.61M | |
| 2 | +$319K | |
| 3 | +$71.2K | |
| 4 |
NPC
National Planning Corporation
El Segundo,
California
|
+$27.7K |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$16K |
Top Sellers
| 1 | -$350K | |
| 2 | -$321K | |
| 3 | -$198K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$59K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.5K |